Latest News

STAT Plus: The founder of Adimab believes he can combat Covid-19 — and whatever pandemic comes next

One of biotech’s most respected entrepreneurs is betting the novel coronavirus won’t be the last deadly outbreak in his lifetime — and that vaccines won’t be enough to stop a future pandemic from bringing the world to a halt once more.

Tillman Gerngross, the Dartmouth bioengineering professor behind the biotech company Adimab, has founded a new firm dedicated to making antibodies that could protect against the novel coronavirus, called SARS-CoV-2, in addition to any future coronaviruses that might make the leap from animals to humans.

Continue to STAT Plus to read the full story…

Source link

Related posts

Spinal implants could one day restore the ability to stand, walk in patients with paralysis


Medical News Today: What to know about ventriculoperitoneal shunt


Is the new 'fasting' diet trend healthy?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World